U.S. Life Sciences Industry Digitizing to Meet Pandemic-Related Demands
ISG Provider Lens™ report reveals accelerated digital transformation in U.S. life sciences, particularly MedTech, due to COVID-19. The report identifies trends such as increased demand for innovation in wearables, AI, and automation. MedTech companies are adopting digital solutions for improved supply chain visibility and reduced R&D costs. However, regulatory scrutiny is rising, prompting companies to seek external support for data management and compliance. The report evaluates 19 providers, naming Cognizant, TCS, and Wipro as Leaders.
- Digital transformation in MedTech accelerating due to COVID-19.
- Increased demand for AI, wearables, and automation improving business operations.
- Cognizant, TCS, and Wipro recognized as leaders in digital transformation services.
- Growing regulatory scrutiny may increase operational challenges.
- Life sciences companies historically reluctant to outsource key functions.
ISG Provider Lens™ report sees life sciences companies in the country looking to take advantage of innovations in wearables, artificial intelligence and automation
The 2021 ISG Provider Lens™ Life Sciences Digital Services Report for the
MedTech providers find themselves at the intersection of multiple influences, the report says. These include significant leaps in the capabilities of devices, wearables, AI and automation; sudden increased demand from both the life sciences industry and patient populations; new opportunities in IoT, and the need for upskilled resources.
“The pandemic has accelerated the digital transformation of the MedTech industry, changing its approach to business and the way healthcare systems interact with medical device companies,” said
Stein noted the industry has an opportunity to drive new sources of growth and improve patient care through digital solutions, but it has a lot of ground to cover. “Through the use of digital technologies, MedTech companies can increase supply chain visibility, reduce maintenance and R&D costs, and deliver greater customer satisfaction and improved patient experience,” she said.
The medical device industry, in which the
The report also notes that life sciences companies are under increasing scrutiny, from both regulatory agencies and consumer watchdog groups, to ensure patient safety and monitor quality and compliance. The industry’s pharmacovigilance and regulatory affairs functions have traditionally been reluctant to rely on outsourcing, the report says, but the increased volume of data and growing regulatory requirements have them rethinking that position. Life sciences companies are looking for providers that can leverage AI, natural language processing, machine learning and automation to deliver the insights, analytics and reporting needed for regulatory compliance and patient safety.
The report finds the COVID-19 pandemic has been a catalyst for record increases in employment and venture capital funding in the
The 2021 ISG Provider Lens™ Life Sciences Digital Services Report for the
The report names Cognizant, TCS and Wipro as Leaders in both quadrants and Accenture,
In addition, Harmon and HCL were named Rising Stars—companies with “promising portfolios” and “high future potential” by ISG’s definition—in one quadrant.
A customized version of the report is available from LTTS.
The 2021 ISG Provider Lens™ Life Sciences Digital Services Report for the
About ISG Provider Lens™ Research
The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across
A companion research series, the ISG Provider Lens Archetype reports, offer a first-of-its-kind evaluation of providers from the perspective of specific buyer types.
About ISG
ISG (
View source version on businesswire.com: https://www.businesswire.com/news/home/20220202005555/en/
Press:
+1 203 517 3119
will.thoretz@isg-one.com
+1 617 755 2985
isg@matternow.com
Source:
FAQ
What does the ISG Provider Lens™ report reveal about U.S. life sciences companies and digital transformation?
Who are the leaders identified in the 2021 ISG Provider Lens™ Life Sciences Digital Services Report?
How is regulatory scrutiny affecting life sciences companies according to the report?
What opportunities for growth are mentioned in the ISG report for MedTech companies?